Literature DB >> 2963585

Tau antisera recognize neurofibrillary tangles in a range of neurodegenerative disorders.

C L Joachim1, J H Morris, K S Kosik, D J Selkoe.   

Abstract

Neurofibrillary tangles occur in a number of apparently distinct neurodegenerative diseases and in normal aging of the human brain. Antibodies raised against Alzheimer's disease paired helical filaments immunolabel the tangles seen in all other tangle-associated disorders examined to date. The neuronal microtubule-associated protein, tau, has recently been identified as an antigenic component of neurofibrillary tangles and senile plaque neurites in Alzheimer's disease. Three different polyclonal antibodies with strong tau immunoreactivity are examined in this study. These antibodies were found to immunostain tangles in normal aged brain and in brains affected by a range of neurodegenerative disorders, including Down's syndrome, Alzheimer's disease plus Parkinson's disease, progressive supranuclear palsy, and the parkinsonism-dementia complex of Guam, as well as Pick bodies in Pick's disease. The findings further illustrate the relative nonspecificity of neurofibrillary lesions in neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2963585     DOI: 10.1002/ana.410220411

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  38 in total

1.  Presence of two different fibril subtypes in the Pick body: an immunoelectron microscopic study.

Authors:  S Kato; H Nakamura
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

2.  Topographical relationship between beta-amyloid and tau protein epitopes in tangle-bearing cells in Alzheimer disease.

Authors:  M G Spillantini; M Goedert; R Jakes; A Klug
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

3.  Secondary deposition of beta amyloid within extracellular neurofibrillary tangles in Alzheimer-type dementia.

Authors:  H Yamaguchi; Y Nakazato; M Shoji; K Okamoto; Y Ihara; M Morimatsu; S Hirai
Journal:  Am J Pathol       Date:  1991-03       Impact factor: 4.307

4.  Aluminum neurotoxicity in mammals.

Authors:  H M Wisniewski; R C Moretz; J A Sturman; G Y Wen; J W Shek
Journal:  Environ Geochem Health       Date:  1990-03       Impact factor: 4.609

5.  Microanalysis of Alzheimer disease NFT and plaques.

Authors:  R C Moretz; K Iqbal; H M Wisniewski
Journal:  Environ Geochem Health       Date:  1990-03       Impact factor: 4.609

6.  Neuronal and glial tau-positive inclusions in diverse neurologic diseases share common phosphorylation characteristics.

Authors:  T Iwatsubo; M Hasegawa; Y Ihara
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

7.  Mechanisms of cell death in cholinergic basal forebrain neurons in chronic alcoholics.

Authors:  K M Cullen; G M Halliday
Journal:  Metab Brain Dis       Date:  1995-03       Impact factor: 3.584

8.  Occurrence of 15-nm-wide straight tubules in neocortical neurons in progressive supranuclear palsy.

Authors:  H Takahashi; K Oyanagi; S Takeda; K Hinokuma; F Ikuta
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

9.  Pazopanib Reduces Phosphorylated Tau Levels and Alters Astrocytes in a Mouse Model of Tauopathy.

Authors:  Monica Javidnia; Michaeline L Hebron; Yue Xin; Nikolas G Kinney; Charbel E-H Moussa
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 10.  Interactions Between α-Synuclein and Tau Protein: Implications to Neurodegenerative Disorders.

Authors:  Xuling Li; Simon James; Peng Lei
Journal:  J Mol Neurosci       Date:  2016-09-15       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.